Restless Leg Syndrome More Common in Psoriasis Patients

THURSDAY, Dec. 15, 2022 (HealthDay News) -- Restless leg syndrome (RLS) is more common in psoriasis patients and is associated with more severe psoriasis, according to a study published online Dec. 5 in the International Journal of Dermatology.
Berna Solak, M.D., from Sakarya University in Adapazarı, Turkey, and colleagues conducted a cross-sectional study to examine whether psoriasis is associated with RLS. The study included 70 psoriasis patients and 70 controls without any skin disorder.
The researchers found that the frequency of RLS was 18.6 and 5.7 percent in patients with psoriasis and controls, respectively. Body mass index (BMI), Dermatology Life Quality Index (DLQI), International RLS Rating Scale (IRLSRS), hemoglobin, ferritin, C-reactive protein (CRP), and uric acid levels were significantly higher in psoriasis patients than controls. The Psoriasis Area and Severity Index (PASI), DLQI, Pittsburgh Sleep Quality Index, IRLSRS scores, CRP levels, and BMI were significantly higher in psoriasis patients with RLS compared with psoriasis patients without RLS, and hemoglobin level was significantly lower. The only independent associate of RLS presence in psoriasis patients was PASI score.
"The association of psoriasis and RLS might be owing to increased systemic inflammation frequently seen in psoriasis patients," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
In California Study, Many Veterans at Risk of Suicide Have Unlocked Gun at Home
FRIDAY, April 28, 2023 (HealthDay News) -- A new study on veterans, gun storage,...
Injected Birth Control Could Be Game-Changer to Curb Stray Cat Populations
TUESDAY, June 6, 2023 (HealthDay News) -- Millions of stray cats roam the world...
U.S. Traffic Deaths Rise to Highest Level Since 2007
THURSDAY, March 3, 2022 (HealthDay News) -- Even though Americans drove less in...
FDA Approves Second Drug for Alzheimer Disease, Despite Safety Concerns
FRIDAY, Jan. 6, 2023 (HealthDay News) -- The U.S. Food and Drug Administration...